A Comparison of the Accuracy of Toric Intraocular Lens Formulas

Sponsor
Wenzhou Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT04776603
Collaborator
(none)
172
1
60
2.9

Study Details

Study Description

Brief Summary

To compare the accuracy of the Abulafia-Koch, the Barrett, the Barrett Post ,the EVO , the new Holladay with total surgical-induced astigmatism, the Kane and and the Næser-Savini toric intraocular lens (IOL) power formulas using a large database of toric IOL refractive outcomes

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    To compare the accuracy of the Abulafia-Koch, the Barrett, the Barrett Post ,the EVO , the new Holladay with total surgical-induced astigmatism, the Kane and and the Næser-Savini toric intraocular lens (IOL) power formulas using a large database of toric IOL refractive outcomes.Retrospective consecutive case series.One hundred seventy-two eyes of 172 patients who had a toric IOL inserted during surgery.One eligible eye from patients having uncomplicated cataract surgery with insertion of an Alcon SN6AT(2-9) IOL (Alcon Laboratories, Inc, Fort Worth, TX) from 1 surgeon were included in the study. pre-operative were measured using either the IOLMaster 500 or 700 (Carl Zeiss Meditec AG, Jena, Germany). Using vector calculation, the predicted postoperative refractive astigmatism was calculated for each formula. This was compared with the actual postoperative refractive astigmatism to give the prediction error.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    172 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    A Comparison of the Accuracy of Many Different Toric Intraocular Lens Formulas
    Actual Study Start Date :
    Jan 1, 2015
    Actual Primary Completion Date :
    Dec 1, 2019
    Actual Study Completion Date :
    Jan 1, 2020

    Arms and Interventions

    Arm Intervention/Treatment
    Group 1

    group 1 includes patients who axial length(AL)<26mm

    Group 2

    group 2 includes patients who axial length(AL)≥26mm

    Outcome Measures

    Primary Outcome Measures

    1. A Comparison of the Accuracy of Toric Intraocular Lens Formulas [5 years]

      percentage of eyes with a prediction error within ±0.50 diopter (D)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years to 90 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • uncomplicated cataract surgery with a temporal clear corneal incision,with preoperative biometry using either the IOLMaster 500 (softwareversions 5.5 and 7.7) or 700 (software version 1.50; Carl Zeiss Meditec AG, Jena, Germany)

    • subjective manifest refraction performed by any of the orthoptists in the practice and measurement of the actual postoperative axis of the IOL alignment performed in the same visit an average of 1 or 3months after surgery.

    Exclusion Criteria:
    • any corneal disease (keratoconus, other ectasia, pterygium, or previous trauma);

    • previous ophthalmic operations, including laser vision correction, vitrectomy, pterygium surgery, penetrating glaucoma surgery, or scleral buckling procedures

    • intraoperative or postoperative complications

    • postoperative corrected distance visual acuity worse than 6/9

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Zhejiang China

    Sponsors and Collaborators

    • Wenzhou Medical University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Yune Zhao, Vice president of Eye Hospital of Wenzhou Medical University, Wenzhou Medical University
    ClinicalTrials.gov Identifier:
    NCT04776603
    Other Study ID Numbers:
    • Toric-CPJ
    First Posted:
    Mar 1, 2021
    Last Update Posted:
    Mar 1, 2021
    Last Verified:
    Feb 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Yune Zhao, Vice president of Eye Hospital of Wenzhou Medical University, Wenzhou Medical University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 1, 2021